Mml Investors Services, LLC Adaptive Biotechnologies Corp Transaction History

Mml Investors Services, LLC

  • $29 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020
SELL
$16.96 - $34.16 $114,344 - $230,306
-6,742 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
$24.56 - $32.8 $165,583 - $221,137
6,742 New
6,742 $202,000

Others Institutions Holding ADPT

# of Institutions
224
Shares Held
146M
Call Options Held
19.6K
Put Options Held
27.2K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.18B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email